Ontology highlight
ABSTRACT: Background
The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils, is unclear.Methods
Cross-sectional study comprising 72 clinically stable COPD patients (mean age 68 [SD 7.9] years; FEV1 48.7 [SD 20.1]% of reference) who provided spontaneous sputum samples for 16S rRNA gene amplification and sequencing. The microbiome composition was analysed with QIIME.Results
We observed that: (1) more severe airflow limitation was associated with reduced relative abundance (RA) of Treponema and an increase in Pseudomonas; (2) patients with ≥2 exacerbations the previous year showed a significantly different bacterial community with respect to non-exacerbators (p = 0.014), with changes in 13 genera, including an increase of Pseudomonas, and finally, (3) peripheral eosinophils levels ≥2% were associated with more diverse microbiome [Chao1 224.51 (74.88) vs 277.39 (78.92) p = 0.006; Shannon 3.94 (1.05) vs 4.54 (1.06) p = 0.020], and a significant increase in the RAs of 20 genera.Conclusion
The respiratory microbiome in clinically stable COPD patients varies significantly according to the severity of airflow limitation, previous history of exacerbations and circulating eosinophils levels.
SUBMITTER: Millares L
PROVIDER: S-EPMC6591812 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
Millares Laura L Pascual Sergi S Montón Concepción C García-Núñez Marian M Lalmolda Cristina C Faner Rosa R Casadevall Carme C Setó Laia L Capilla Silvia S Moreno Amàlia A Castro-Acosta Ady Angélica AA Alvarez-Martinez Carlos José CJ Sibila Oriol O Peces-Barba Germán G Cosio Borja G BG Agustí Alvar A Gea Joaquim J Monsó Eduard E
BMC pulmonary medicine 20190624 1
<h4>Background</h4>The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils, is unclear.<h4>Methods</h4>Cross-sectional study comprising 72 clinically stable COPD patients (mean age 68 [SD 7.9] years; FEV1 48.7 [SD 20.1]% of reference) who provided spontaneous sputum samples for 16S rRNA gene amplification and sequencing. The ...[more]